Granules India Ltd

GRANULES Stock View

(NSE)

341.85

8,373.47
Proj. ROE (%)
18.10
Proj. P/E (x)
15.93
Proj EV / EBITDA (x)
10.15
Proj. P/BV (x)
2.78
Proj. Revenue ( Cr.)
4,386.02

Stock View

BUY
Share on
The average score for Granules India Ltd stands at 7 against 7, three months back.

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
350.55
100 DMA ()
328.19
200 DMA ()
305.50
52 Weeks Range
226.95
381.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp